Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

820

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions

Chronic Non-specific Low Back Pain

Interventions

DRUG

VER-01

standardised cannabis extract (containing 21 mg THC per gram drug product)

OTHER

Placebo

comparator without active ingredient

Trial Locations (1)

Emovis GmbH, Berlin

All Listed Sponsors

lead

Vertanical GmbH

INDUSTRY